메뉴 건너뛰기





Volumn 16, Issue 3-4, 2007, Pages 137-158

Cumulative updating of approved biopharmaceuticals

Author keywords

[No Author keywords available]

Indexed keywords

ADVATA; AGALSIDASE BETA; ALEFACEPT; ALTEPLASE; ARCITUMOMAB TC 99M; BETA1A INTERFERON; BEVACIZUMAB; CETUXIMAB; CHOLERA VACCINE; ETANERCEPT; EXENDIN 4; GAMMA1B INTERFERON; HAEMOPHILUS INFLUENZAE TYPE B HEPATITIS B VACCINE; HEPATITIS A HEPATITIS B VACCINE; HEPATITIS B VACCINE; IDURONATE 2 SULFATASE; IMIGLUCERASE; INSULIN GLULISINE; INTERFERON BETA SERINE; LARONIDASE; PARATHYROID HORMONE[1-34]; RASBURICASE; RECOMBINANT ANTITHROMBIN III; RECOMBINANT BLOOD CLOTTING FACTOR 8; RECOMBINANT BLOOD CLOTTING FACTOR 9; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT HEPATITIS B VACCINE; RECOMBINANT HUMAN INSULIN; SALCATONIN; TASONERMIN; TOSITUMOMAB I 131; UNCLASSIFIED DRUG; UNINDEXED DRUG; WART VIRUS VACCINE;

EID: 40549145848     PISSN: 10932607     EISSN: None     Source Type: Journal    
DOI: 10.3233/hab-2007-163-408     Document Type: Article
Times cited : (34)

References (9)
  • Reference 정보가 존재하지 않습니다.

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.